Literature DB >> 23995581

Dietary tyrosine/phenylalanine depletion effects on behavioral and brain signatures of human motivational processing.

James M Bjork1, Steven J Grant1, Gang Chen2, Daniel W Hommer3.   

Abstract

Dopamine (DA) neurotransmission is critical for motivational processing. We assessed whether disruption of DA synthesis in healthy controls using an amino-acid beverage devoid of catecholamine precursors (tyrosine-phenylalanine depletion (TPD)) would blunt recruitment of the nucleus accumbens (NAcc) by rewards. Sixteen controls ingested each of a tyr/phe-depleting beverage (DEP) or a tyr/phe-balanced (BAL) control beverage in two laboratory visits. Five hours after consumption of each drink, subjects underwent functional magnetic resonance imaging while they viewed anticipatory cues to respond to a target to either win money or avoid losing money. TPD did not exert main effects on mood or on task behavior, but affected brain activation. In right NAcc, TPD blunted activation by anticipation of high rewards. In left NAcc, recruitment anticipating high rewards was modulated by individual differences in mood change across the DEP drink day, where subjects whose mood worsened following TPD (relative to within-day mood change under BAL conditions) also showed lower activation under DEP conditions relative to BAL conditions. Exploratory analysis indicated that TPD qualitatively blunted the voxel-wise spatial extent of suprathreshold activation by reward anticipation. Finally, loss outcomes activated anterior insula under DEP conditions but not under BAL conditions. These data indicate that: (1) dietary depletion of catacholamine precursors will blunt dopaminergic mesolimbic activity, and (2) in controls, synthetic pathways of this neurocircuitry maintain sufficient buffering capacity to resist an effect on motivated behavior. Additional studies are needed to determine if clinical populations would show similar resistance to behavioral effects of TPD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995581      PMCID: PMC3895237          DOI: 10.1038/npp.2013.232

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  37 in total

1.  Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo.

Authors:  S F McTavish; L Callado; P J Cowen; T Sharp
Journal:  J Psychopharmacol       Date:  1999-12       Impact factor: 4.153

2.  Anticipation of increasing monetary reward selectively recruits nucleus accumbens.

Authors:  B Knutson; C M Adams; G W Fong; D Hommer
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 3.  The relevance of behavioural measures for functional-imaging studies of cognition.

Authors:  David Wilkinson; Peter Halligan
Journal:  Nat Rev Neurosci       Date:  2004-01       Impact factor: 34.870

4.  Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients.

Authors:  S F B McTavish; Z N Mannie; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  2004-07-01       Impact factor: 4.530

5.  Incentive-elicited brain activation in adolescents: similarities and differences from young adults.

Authors:  James M Bjork; Brian Knutson; Grace W Fong; Daniel M Caggiano; Shannon M Bennett; Daniel W Hommer
Journal:  J Neurosci       Date:  2004-02-25       Impact factor: 6.167

6.  From anticipation to action, the role of dopamine in perceptual decision making: an fMRI-tyrosine depletion study.

Authors:  Atsuko Nagano-Saito; Paul Cisek; Andrea S Perna; Fatemeh Z Shirdel; Chawki Benkelfat; Marco Leyton; Alain Dagher
Journal:  J Neurophysiol       Date:  2012-05-02       Impact factor: 2.714

7.  Tyrosine depletion attenuates the behavioural stimulant effects of amphetamine and cocaine in rats.

Authors:  S F McTavish; B Raumann; P J Cowen; T Sharp
Journal:  Eur J Pharmacol       Date:  2001-07-20       Impact factor: 4.432

8.  Tyrosine depletion attenuates dopamine function in healthy volunteers.

Authors:  C J Harmer; S F McTavish; L Clark; G M Goodwin; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

9.  Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study.

Authors:  N Coupland; L Zedkova; G Sanghera; M Leyton; J M Le Mellédo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 10.  Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.

Authors:  K Blum; E R Braverman; J M Holder; J F Lubar; V J Monastra; D Miller; J O Lubar; T J Chen; D E Comings
Journal:  J Psychoactive Drugs       Date:  2000-11
View more
  13 in total

1.  Modafinil augments brain activation associated with reward anticipation in the nucleus accumbens.

Authors:  Takuya Funayama; Yumiko Ikeda; Amane Tateno; Hidehiko Takahashi; Yoshiro Okubo; Haruhisa Fukayama; Hidenori Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

Review 2.  Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model.

Authors:  Marco Leyton; Paul Vezina
Journal:  Trends Pharmacol Sci       Date:  2014-04-30       Impact factor: 14.819

Review 3.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

4.  Effects of Methylphenidate on the Dopamine Transporter and Beyond.

Authors:  Tyra S C Zetterström; Emmanuel Quansah; Martin Grootveld
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  Dopamine Depletion Reduces Food-Related Reward Activity Independent of BMI.

Authors:  Sabine Frank; Ralf Veit; Helene Sauer; Paul Enck; Hans-Christoph Friederich; Theresa Unholzer; Ute-Maria Bauer; Katarzyna Linder; Martin Heni; Andreas Fritsche; Hubert Preissl
Journal:  Neuropsychopharmacology       Date:  2015-10-09       Impact factor: 7.853

6.  The effect of risperidone on reward-related brain activity is robust to drug-induced vascular changes.

Authors:  Peter C T Hawkins; Fernando O Zelaya; Owen O'Daly; Stefan Holiga; Juergen Dukart; Daniel Umbricht; Mitul A Mehta
Journal:  Hum Brain Mapp       Date:  2021-03-05       Impact factor: 5.038

7.  Levodopa reverses cytokine-induced reductions in striatal dopamine release.

Authors:  Jennifer C Felger; Carla R Hernandez; Andrew H Miller
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-31       Impact factor: 5.176

Review 8.  Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults.

Authors:  Heather E Webber; Paula Lopez-Gamundi; Sydney N Stamatovich; Harriet de Wit; Margaret C Wardle
Journal:  Neurosci Biobehav Rev       Date:  2020-11-14       Impact factor: 8.989

9.  No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers.

Authors:  Oliver Grimm; Magdalena Nägele; Lea Küpper-Tetzel; Moritz de Greck; Michael Plichta; Andreas Reif
Journal:  Psychopharmacology (Berl)       Date:  2020-11-02       Impact factor: 4.530

10.  Acute depletion of dopamine precursors in the human brain: effects on functional connectivity and alcohol attentional bias.

Authors:  Amanda Elton; Monica L Faulkner; Donita L Robinson; Charlotte A Boettiger
Journal:  Neuropsychopharmacology       Date:  2021-03-16       Impact factor: 8.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.